Northeast Pharmaceutical Group Co Ltd (000597) — Capital Reinvestment Ratio
Northeast Pharmaceutical Group Co Ltd (000597) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥274.09 Million) in capital expenditures (CN¥11.48 Million). Check 000597 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Northeast Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Northeast Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see Northeast Pharmaceutical Group Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd from 1999 to 2025. See 000597 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥1.11 Billion | CN¥97.78 Million | ▼ -57.9% |
| 2024 | 0.21x | CN¥758.76 Million | CN¥159.43 Million | ▼ -47.6% |
| 2023 | 0.40x | CN¥586.75 Million | CN¥235.43 Million | ▲ +82.2% |
| 2022 | 0.22x | CN¥1.11 Billion | CN¥244.13 Million | ▲ +37.2% |
| 2021 | 0.16x | CN¥746.51 Million | CN¥119.81 Million | ▼ -77.1% |
| 2020 | 0.70x | CN¥570.92 Million | CN¥400.38 Million | ▲ +7.9% |
| 2019 | 0.65x | CN¥352.60 Million | CN¥229.17 Million | ▼ -67.2% |
| 2018 | 1.98x | CN¥285.09 Million | CN¥565.74 Million | ▲ +331.1% |
| 2016 | 0.46x | CN¥384.51 Million | CN¥177.01 Million | ▼ -86.7% |
| 2015 | 3.47x | CN¥99.70 Million | CN¥346.04 Million | ▼ -69.4% |
| 2014 | 11.33x | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥54.62 Million | CN¥9.41 Million | — |